For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...

Explore the role of depression drugs targeting the neurokinin-1 receptor and their potential impact on major depressive ...

A research team of the University Medical Center Mainz has succeeded in observing for the first time how G protein-coupled ...

Scientists led by a team at the Medical Research Council (MRC) Mitochondrial Biology Unit, University of Cambridge, have worked out how a molecular machine found in mitochondria—the “powerhouses” of ...

Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...

Research on the genome of the virus that causes severe acute respiratory syndrome (SARS) has revealed an unusual molecular structure that looks like a promising target for antiviral drugs. A team of ...

Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...

Designing drugs is a bit like playing with Polly Pocket. The vintage toy is a plastic clam shell that contains a multi-bedroom house, a skating rink, a disco dance floor, and other fun scenarios. Kids ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

When new medicines are invented, the drug may hit the intended target and nullify the symptoms, but nailing a bull's eye - one that produces zero side effects - can be quite elusive. New research ...